有血流动力学意义的动脉导管未闭早产儿布洛芬治疗失败的危险因素分析

吴梓琪, 张漪, 周茜茜, 刘沁, 程实, 夏世文

中国当代儿科杂志 ›› 2024, Vol. 26 ›› Issue (4) : 343-349.

PDF(588 KB)
HTML
PDF(588 KB)
HTML
中国当代儿科杂志 ›› 2024, Vol. 26 ›› Issue (4) : 343-349. DOI: 10.7499/j.issn.1008-8830.2310145
论著·临床研究

有血流动力学意义的动脉导管未闭早产儿布洛芬治疗失败的危险因素分析

  • 吴梓琪1, 张漪1, 周茜茜1, 刘沁2, 程实3, 夏世文1
作者信息 +

Risk factors for the failure of ibuprofen treatment in preterm infants with hemodynamically significant patent ductus arteriosus

  • WU Zi-Qi, ZHANG Yi, ZHOU Qian-Qian, LIU Qin, CHENG Shi, XIA Shi-Wen
Author information +
文章历史 +

摘要

目的 研究有血流动力学意义的动脉导管未闭(hemodynamically?significant?patent?ductus?arteriosus, hsPDA)早产儿布洛芬治疗失败的高危因素。 方法 回顾性收集华中科技大学同济医学院附属湖北妇幼保健院新生儿科2018年1月—2023年6月收治的胎龄<34周hsPDA早产儿的临床资料,根据治疗方式的不同分为布洛芬组(95例)和布洛芬+手术组(44例),采用二元logistic回归分析探讨hsPDA早产儿布洛芬治疗失败的高危因素。 结果 二元logistic回归分析显示,动脉导管直径增大、大脑中动脉阻力指数(resistance index, RI)值≥0.80、总有创机械通气时间延长是hsPDA早产儿布洛芬治疗失败的高危因素(P<0.05)。受试者操作特征曲线分析显示,动脉导管直径>2.85 mm,大脑中动脉RI值≥0.80,总有创机械通气时间>16 d对hsPDA早产儿布洛芬治疗失败具有预测价值(P<0.05);三者联合预测价值最高,曲线下面积为0.843,灵敏度为86.5%,特异度75.0%(P<0.05)。 结论 动脉导管直径>2.85 mm、大脑中动脉RI值≥0.80、总有创机械通气时间>16 d是hsPDA早产儿布洛芬治疗失败的高危因素,并对临床上布洛芬治疗失败需手术治疗具有重要参考意义。

Abstract

Objective To investigate the risk factors for the failure of ibuprofen treatment in preterm infants with hemodynamically significant patent ductus arteriosus (hsPDA). Methods A retrospective collection of clinical data was conducted on preterm infants with a gestational age of <34 weeks who were diagnosed with hsPDA and treated at the Department of Neonatology, Maternal and Child Health Hospital of Hubei Province, Tongji Medical College, Huazhong University of Science and Technology, from January 2018 to June 2023. The subjects were divided into two groups based on the treatment approach: the ibuprofen group (95 cases) and the ibuprofen plus surgery group (44 cases). The risk factors for the failure of ibuprofen treatment in preterm infants with hsPDA were identified by binary logistic regression analysis. Results The binary logistic regression analysis revealed that an increased diameter of the ductus arteriosus, a resistance index (RI) value of the middle cerebral artery ≥0.80, and prolonged total invasive mechanical ventilation time were risk factors for the failure of ibuprofen treatment in preterm infants with hsPDA (P<0.05). Receiver operating characteristic curve analysis showed that a ductus arteriosus diameter >2.85 mm, a middle cerebral artery RI value ≥0.80, and a total invasive mechanical ventilation time >16 days had significant predictive value for the failure of ibuprofen treatment in preterm infants with hsPDA (P<0.05). The combined predictive value of these three factors was the highest, with an area under the curve of 0.843, a sensitivity of 86.5%, and a specificity of 75.0% (P<0.05). Conclusions A ductus arteriosus diameter >2.85 mm, a middle cerebral artery RI value ≥0.80, and a total invasive mechanical ventilation time >16 days are risk factors for the failure of ibuprofen treatment in preterm infants with hsPDA, and they are of significant predictive value for the necessity of surgical treatment following the failure of ibuprofen treatment.

关键词

动脉导管未闭 / 布洛芬治疗 / 动脉导管未闭手术结扎 / 高危因素 / 早产儿

Key words

Patent ductus arteriosus / Ibuprofen treatment / Surgical ligation of the ductus arteriosus / Risk factor / Preterm infant

引用本文

导出引用
吴梓琪, 张漪, 周茜茜, 刘沁, 程实, 夏世文. 有血流动力学意义的动脉导管未闭早产儿布洛芬治疗失败的危险因素分析[J]. 中国当代儿科杂志. 2024, 26(4): 343-349 https://doi.org/10.7499/j.issn.1008-8830.2310145
WU Zi-Qi, ZHANG Yi, ZHOU Qian-Qian, LIU Qin, CHENG Shi, XIA Shi-Wen. Risk factors for the failure of ibuprofen treatment in preterm infants with hemodynamically significant patent ductus arteriosus[J]. Chinese Journal of Contemporary Pediatrics. 2024, 26(4): 343-349 https://doi.org/10.7499/j.issn.1008-8830.2310145

参考文献

1 Van Overmeire B, Smets K, Lecoutere D, et al. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus[J]. N Engl J Med, 2000, 343(10): 674-681. PMID: 10974130. DOI: 10.1056/NEJM200009073431001.
2 Mitra S, de Boode WP, Weisz DE, et al. Interventions for patent ductus arteriosus (PDA) in preterm infants: an overview of Cochrane systematic reviews[J]. Cochrane Database Syst Rev, 2023, 4(4): CD013588. PMID: 37039501. PMCID: PMC10091483. DOI: 10.1002/14651858.CD013588.pub2.
3 Abu-Shaweesh JM, Almidani E. PDA: does it matter?[J]. Int J Pediatr Adolesc Med, 2020, 7(1): 9-12. PMID: 32373696. PMCID: PMC7193069. DOI: 10.1016/j.ijpam.2019.12.001.
4 Hamrick SEG, Sallmon H, Rose AT, et al. Patent ductus arteriosus of the preterm infant[J]. Pediatrics, 2020, 146(5): e20201209. PMID: 33093140. PMCID: PMC7605084. DOI: 10.1542/peds.2020-1209.
5 Lago P, Bettiol T, Salvadori S, et al. Safety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: a randomised controlled trial[J]. Eur J Pediatr, 2002, 161(4): 202-207. PMID: 12014386. DOI: 10.1007/s00431-002-0915-y.
6 Ohlsson A, Walia R, Shah SS. Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants[J]. Cochrane Database Syst Rev, 2020, 2(2): CD003481. PMID: 32045960. PMCID: PMC7012639. DOI: 10.1002/14651858.CD003481.pub8.
7 Lee JH, Lee HJ, Park HK, et al. Surgical ligation of patent ductus arteriosus in preterm neonates weighing less than 1500 g: a 9-year single center experience[J]. J Cardiothorac Surg, 2020, 15(1): 144. PMID: 32552772. PMCID: PMC7298442. DOI: 10.1186/s13019-020-01191-2.
8 Malviya MN, Ohlsson A, Shah SS. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants[J]. Cochrane Database Syst Rev, 2013, 2013(3): CD003951. PMID: 23543527. PMCID: PMC7027388. DOI: 10.1002/14651858.CD003951.pub3.
9 姜静婧, 李正红, 张朕杰, 等. 有血流动力学意义的动脉导管未闭早产儿手术治疗危险因素巢式病例对照研究[J]. 中华实用儿科临床杂志, 2023, 38(3): 210-214. DOI: 10.3760/cma.j.cn101070-20220425-00449.
10 Dutta S, Singh B, Chessell L, et al. Guidelines for feeding very low birth weight infants[J]. Nutrients, 2015, 7(1): 423-442. PMID: 25580815. PMCID: PMC4303848. DOI: 10.3390/nu7010423.
11 Moore TA, Wilson ME. Feeding intolerance: a concept analysis[J]. Adv Neonatal Care, 2011, 11(3): 149-154. PMID: 21730906. DOI: 10.1097/ANC.0b013e31821ba28e.
12 邵肖梅, 叶鸿瑁, 丘小汕. 实用新生儿学[M]. 5版. 北京: 人民卫生出版社, 2019.
13 Edstedt Bonamy AK, Gudmundsdottir A, Maier RF, et al. Patent ductus arteriosus treatment in very preterm infants: a European population-based cohort study (EPICE) on variation and outcomes[J]. Neonatology, 2017, 111(4): 367-375. PMID: 28125815. DOI: 10.1159/000454798.
14 Tissot C, Singh Y. Neonatal functional echocardiography[J]. Curr Opin Pediatr, 2020, 32(2): 235-244. PMID: 32068595. DOI: 10.1097/MOP.0000000000000887.
15 Clyman RI. Patent ductus arteriosus, its treatments, and the risks of pulmonary morbidity[J]. Semin Perinatol, 2018, 42(4): 235-242. PMID: 29958703. DOI: 10.1053/j.semperi.2018.05.006.
16 Kluckow M, Evans N. Ductal shunting, high pulmonary blood flow, and pulmonary hemorrhage[J]. J Pediatr, 2000, 137(1): 68-72. PMID: 10891824. DOI: 10.1067/mpd.2000.106569.
17 刘太祥, 马晓路, 陈正, 等. 极低出生体重儿动脉导管未闭手术结扎时机的研究[J]. 中国当代儿科杂志, 2022, 24(5): 500-506. PMID: 35644189. PMCID: PMC9154378. DOI: 10.7499/j.issn.1008-8830.2112151.
18 Toyoshima K, Isayama T, Kobayashi T, et al. What echocardiographic indices are predictive of patent ductus arteriosus surgical closure in early preterm infants? A prospective multicenter cohort study[J]. J Cardiol, 2019, 74(6): 512-518. PMID: 31256929. DOI: 10.1016/j.jjcc.2019.05.004.
19 Masutani S, Isayama T, Kobayashi T, et al. Ductus diameter and left pulmonary artery end-diastolic velocity at 3 days of age predict the future need for surgical closure of patent ductus arteriosus in preterm infants: a post-hoc analysis of a prospective multicenter study[J]. J Cardiol, 2021, 78(6): 487-492. PMID: 34481720. DOI: 10.1016/j.jjcc.2021.08.007.
20 Kwinta P, Rudziński A, Kruczek P, et al. Can early echocardiographic findings predict patent ductus arteriosus?[J]. Neonatology, 2009, 95(2): 141-148. PMID: 18776728. DOI: 10.1159/000153098.
21 孙红光, 於晓平, 戚庭月. 早产儿大脑中动脉血流参数与脑损伤关系的探讨[J]. 医学影像学杂志, 2009, 19(8): 950-952. DOI: 10.3969/j.issn.1006-9011.2009.08.005.
22 Ecury-Goossen GM, Raets MM, Camfferman FA, et al. Resistive indices of cerebral arteries in very preterm infants: values throughout stay in the neonatal intensive care unit and impact of patent ductus arteriosus[J]. Pediatr Radiol, 2016, 46(9): 1291-1300. PMID: 27259991. PMCID: PMC4943974. DOI: 10.1007/s00247-016-3615-x.
23 Weir FJ, Ohlsson A, Myhr TL, et al. A patent ductus arteriosus is associated with reduced middle cerebral artery blood flow velocity[J]. Eur J Pediatr, 1999, 158(6): 484-487. PMID: 10378397. DOI: 10.1007/s004310051125.
24 Camfferman FA, de Goederen R, Govaert P, et al. Diagnostic and predictive value of Doppler ultrasound for evaluation of the brain circulation in preterm infants: a systematic review[J]. Pediatr Res, 2020, 87(Suppl 1): 50-58. PMID: 32218536. PMCID: PMC7098887. DOI: 10.1038/s41390-020-0777-x.
25 Mashally S, Nield LE, McNamara PJ, et al. Late oral acetaminophen versus immediate surgical ligation in preterm infants with persistent large patent ductus arteriosus[J]. J Thorac Cardiovasc Surg, 2018, 156(5): 1937-1944. PMID: 30007780. DOI: 10.1016/j.jtcvs.2018.05.098.
26 Willis KA, Weems MF. Hemodynamically significant patent ductus arteriosus and the development of bronchopulmonary dysplasia[J]. Congenit Heart Dis, 2019, 14(1): 27-32. PMID: 30343505. DOI: 10.1111/chd.12691.

基金

中国疾控中心妇幼中心母婴营养与健康研究项目(2022FYH002)。

PDF(588 KB)
HTML

Accesses

Citation

Detail

段落导航
相关文章

/